High Immunoproteasome and Low Constitutive Proteasome Subunit Levels Correlate With Sensitivity to Bortezomib-Containing Chemotherapy: Update From the Children’s Oncology Group AALL1231 Trial

Authors

• Margot S F Roeten
• Johan Van Meerloo
• Suzanne N Van Dijk
• Zinia Kwidama
• Gaye Jenkins
• David T Teachey
• Meenakshi Devidas
• Mignon L Loh
• Gertjan J L Kaspers
• Sonja Zweegman
• Gerrit Jansen
• Terzah M Horton
• Jacqueline Cloos

Language

English

Publication Date

6-1-2025

Journal

Haematologica

DOI

10.3324/haematol.2024.286171

PMID

39882653

PMCID

PMC12130773

PubMedCentral® Posted Date

1-30-2025

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Recommended Citation

Roeten, Margot S F; Van Meerloo, Johan; Van Dijk, Suzanne N; et al., "High Immunoproteasome and Low Constitutive Proteasome Subunit Levels Correlate With Sensitivity to Bortezomib-Containing Chemotherapy: Update From the Children’s Oncology Group AALL1231 Trial" (2025). Faculty, Staff and Students Publications. 8073.
https://digitalcommons.library.tmc.edu/baylor_docs/8073